MAb 3E10: Began a Phase I trial

MedClone Inc. Product: MAb 3E10 therapeutic vaccine, lupus-related monoclonal antibody Indication: Treat nephritis associated with systemic lupus erythematosus Status: Began a Phase I trial in Switz...